Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05957276 · ClinicalTrials.gov registry record
Global Patient Registry of Inherited Retinal Diseases
A clinical trial of Inherited Retinal Diseases, sponsored by Janssen Research & Development.
- Active
- Registry status
- 891
- Enrollment target
- 20
- Study locations
NCT05957276 is a study of Inherited Retinal Diseases that is active but no longer recruiting, run by Janssen Research & Development. The registered enrollment target is 891 participants. The trial reports 20 study locations across 16 states.
The verdict
NCT05957276, a study of Inherited Retinal Diseases, is active but no longer recruiting, sponsored by Janssen Research & Development.
- ACTIVE NOT RECRUITING
- Registry status
- 891 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to better understand the natural history of Inherited Retinal Disease (IRD) and help inform patient management.
Conditions Studied
Interventions
- OTHER Standard of Care
Study Locations (20)
Texas
- Retina Consultants of Texas - Bellaire
- Baylor College of Medicine - Houston
- University of Texas Houston - Houston
California
- University of Southern California - Los Angeles
- UCSF - San Francisco
Other
- Centre for Eye Research Australia - East Melbourne
- Lions Eye Institute - Nedlands
Alabama
- University of Alabama Birmingham - Birmingham
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Florida
- Bascom Palmer Eye Institute - Miami
Georgia
- Emory University - Atlanta
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 891 participants |
| Start Date | 2023-08-31 |
| Est. Completion | 2026-07-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05957276
The ClinicalTrials.gov registry entry for NCT05957276 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 891 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Inherited Retinal Diseases appearing as the primary indexed condition, and to 1 intervention - of which Standard of Care is the first listed.
NCT05957276 reports 20 study locations spanning 16 distinct geographic areas - top geographies include Texas, California, Other.
Frequently Asked Questions
What is clinical trial NCT05957276 about?
NCT05957276 is a clinical study titled "Global Patient Registry of Inherited Retinal Diseases". The purpose of this study is to better understand the natural history of Inherited Retinal Disease (IRD) and help inform patient management.
What is the current status of trial NCT05957276?
This trial is currently active not recruiting. The enrollment target is 891 participants. The study started on 2023-08-31. Estimated completion is 2026-07-03.
What conditions does trial NCT05957276 study?
This clinical trial studies the following conditions: Inherited Retinal Diseases.
What interventions are being tested in trial NCT05957276?
The interventions under investigation include: Standard of Care (OTHER).
Who is sponsoring clinical trial NCT05957276?
This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05957276 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inherited Retinal Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.